HomeCompareCXBMF vs PFE

CXBMF vs PFE: Dividend Comparison 2026

CXBMF yields 92.17% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CXBMF wins by $2.76M in total portfolio value
10 years
CXBMF
CXBMF
● Live price
92.17%
Share price
$2.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.81M
Annual income
$897,478.47
Full CXBMF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — CXBMF vs PFE

📍 CXBMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCXBMFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CXBMF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CXBMF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CXBMF
Annual income on $10K today (after 15% tax)
$7,834.10/yr
After 10yr DRIP, annual income (after tax)
$762,856.70/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, CXBMF beats the other by $740,536.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CXBMF + PFE for your $10,000?

CXBMF: 50%PFE: 50%
100% PFE50/50100% CXBMF
Portfolio after 10yr
$1.43M
Annual income
$461,868.59/yr
Blended yield
32.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CXBMF
Analyst Ratings
4
Buy
1
Hold
Consensus: Buy
Altman Z
2.6
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CXBMF buys
0
PFE buys
0
No recent congressional trades found for CXBMF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCXBMFPFE
Forward yield92.17%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$2.81M$49.6K
Annual income after 10y$897,478.47$26,258.71
Total dividends collected$2.49M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: CXBMF vs PFE ($10,000, DRIP)

YearCXBMF PortfolioCXBMF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$19,917$9,216.59$9,153$693.39+$10.8KCXBMF
2$38,466$17,155.42$8,593$849.25+$29.9KCXBMF
3$72,125$30,965.76$8,336$1,066.78+$63.8KCXBMF
4$131,436$54,262.79$8,437$1,384.80+$123.0KCXBMF
5$233,053$92,416.55$9,013$1,875.40+$224.0KCXBMF
6$402,513$153,146.25$10,306$2,680.72+$392.2KCXBMF
7$677,889$247,199.53$12,820$4,101.38+$665.1KCXBMF
8$1,114,424$389,082.88$17,673$6,826.70+$1.10MCXBMF
9$1,790,226$597,792.36$27,543$12,591.86+$1.76MCXBMF
10$2,813,020$897,478.47$49,560$26,258.71+$2.76MCXBMF

CXBMF vs PFE: Complete Analysis 2026

CXBMFStock

Calibre Mining Corp., together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties. It primarily explores for gold, silver, and copper deposits. The company holds 100% interests in the El Limon and La Libertad gold mines, the Pavon gold project, and other mineral concessions in Nicaragua, Central America; and the Borosi Gold-Silver-Copper project located in the North Atlantic Autonomous Region of Nicaragua, Central America. It also holds 100% interests in the Pan Mine gold project, the Gold Rock project, and the Illipah Gold project in Nevada, the United States, as well as the Golden Eagle project in Washington State, the United States. The company was formerly known as TLC Ventures Corp. and changed its name to Calibre Mining Corp. in June 2007. Calibre Mining Corp. was founded in 1969 and is headquartered in Vancouver, Canada.

Full CXBMF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CXBMF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CXBMF vs SCHDCXBMF vs JEPICXBMF vs OCXBMF vs KOCXBMF vs MAINCXBMF vs JNJCXBMF vs MRKCXBMF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.